Defendant Name:
Alexion Pharmaceuticals, Inc.
Defendant Type:
Public Company
Document Reference:
2020-149
Document Details
Legal Case Name
In the Matter of Alexion Pharmaceuticals, Inc.
Document Name
SEC Charges Alexion Pharmaceuticals with FCPA Violations
Document Date
02-Jul-2020
Document Format
Administrative Proceeding
Allegation Type
Foreign Corrupt Practices Act
Document Summary
The SEC stated that: "Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA)."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
Monetary Penalties:
Disgorgement
Individual:
$14,210,194.00
Shared:
Civil Penalty
Individual:
$3,500,000.00
Shared:
Pre-Judgment Interest
Individual:
$3,766,337.00
Shared: